140 related articles for article (PubMed ID: 4039346)
1. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
Addonizio VP; Strauss JF; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
[TBL] [Abstract][Full Text] [Related]
3. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
4. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
Corby DG; O'Barr TP
Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
[TBL] [Abstract][Full Text] [Related]
5. Interactions of agonists with platelet alpha 2-adrenergic receptors.
Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
[TBL] [Abstract][Full Text] [Related]
6. The alpha adrenergic response of Down's syndrome platelets.
Sheppard JR; Schumacher W; White JG; Jakobs KH; Schultz G
J Pharmacol Exp Ther; 1983 Jun; 225(3):584-8. PubMed ID: 6306212
[TBL] [Abstract][Full Text] [Related]
7. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.
Mehta J; Mehta P; Ostrowski N
J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219
[TBL] [Abstract][Full Text] [Related]
8. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation.
Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E
Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252
[TBL] [Abstract][Full Text] [Related]
9. Alpha-2-adrenoreceptor density on intact platelets and adrenaline-induced platelet aggregation in endurance- and nonendurance-trained subjects.
Lehmann M; Hasler K; Bergdolt E; Keul J
Int J Sports Med; 1986 Jun; 7(3):172-6. PubMed ID: 3015811
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
11. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.
Kaywin P; McDonough M; Insel PA; Shattil SJ
N Engl J Med; 1978 Sep; 299(10):505-9. PubMed ID: 210377
[TBL] [Abstract][Full Text] [Related]
13. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
Addonizio VP; Fisher CA; Jenkin BK; Strauss JF; Musial JF; Edmunds LH
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
[TBL] [Abstract][Full Text] [Related]
14. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
15. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation.
Musial J; Niewiarowski S; Hershock D; Morinelli TA; Colman RW; Edmunds LH
J Lab Clin Med; 1985 Apr; 105(4):514-22. PubMed ID: 2984300
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
Nakaki T; Nakadate T; Yamamoto S; Kato R
J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
[TBL] [Abstract][Full Text] [Related]
17. Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
Villeneuve A; Berlan M; Paris H; Tran MA; Lafontan M; Montastruc JL; Montastruc P
J Pharmacol; 1986; 17(4):644-50. PubMed ID: 3031380
[TBL] [Abstract][Full Text] [Related]
18. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
[TBL] [Abstract][Full Text] [Related]
19. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
Woodcock EA; Johnston CI
Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
[TBL] [Abstract][Full Text] [Related]
20. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
